AxoGen, Inc. (AXGN) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 731 transactions totaling $95.2M, demonstrating a bearish sentiment with -$88.5M in net insider flow. The most recent transaction on Dec 16, 2025 involved a sale of 21,825 shares valued at $644.9K.
No significant insider buying has been recorded for AXGN in the recent period.
No significant insider selling has been recorded for AXGN in the recent period.
Based on recent SEC filings, insider sentiment for AXGN is bearish with an Insider Alignment Score of 4/100 and a net flow of -$88.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AxoGen, Inc. (AXGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading AXGN stock, having executed 731 transactions in the past 90 days. The most active insider is Guido J. Neels (Executive), who has made 12 transactions totaling $23.1M.
Get notified when executives and directors at AXGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Johnson Weiler Kathy | Executive | Sale | 21,825 | $29.55 | $644.9K | Large |
| Dec 16, 2025 | Johnson Weiler Kathy | Executive | Sale | 18,248 | $29.55 | $539.2K | Large |
| Dec 16, 2025 | Johnson Weiler Kathy | Executive | Sale | 6,580 | $29.55 | $194.4K | |
| Dec 16, 2025 | Johnson Weiler Kathy | Executive | Option Exercise | 21,825 | $6.95 | $151.7K | |
| Dec 16, 2025 | Johnson Weiler Kathy | Executive | Option Exercise | 18,248 | $7.04 | $128.5K | |
| Dec 16, 2025 | Mcbride Wendell Amy | Executive | Option Exercise | 18,248 | $7.04 | $128.5K | |
| Dec 16, 2025 | Mcbride Wendell Amy | Executive | Sale | 20,436 | $29.31 | $599.0K | Large |
| Dec 16, 2025 | Mcbride Wendell Amy | Executive | Sale | 5,000 | $29.31 | $146.6K | |
| Dec 16, 2025 | Mcbride Wendell Amy | Executive | Sale | 18,248 | $29.31 | $534.8K | Large |
| Dec 16, 2025 | Mcbride Wendell Amy | Executive | Option Exercise | 5,000 | $8.95 | $44.8K | |
| Dec 16, 2025 | Mcbride Wendell Amy | Executive | Option Exercise | 20,436 | $6.30 | $128.7K | |
| Dec 15, 2025 | Marie Hartley Lindsey | Executive | Sale | 14,812 | $29.86 | $442.3K | |
| Dec 15, 2025 | Marie Hartley Lindsey | Executive | Option Exercise | 14,812 | $8.27 | $122.5K | |
| Dec 11, 2025 | A. Began Marc | Executive | Sale | 13,222 | $30.00 | $396.7K | |
| Dec 10, 2025 | D. Dale Michael | Executive | Sale | 25,000 | $30.00 | $750.0K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 143 | $91.9M | 81.7% |
Exercise(M) | 211 | $10.6M | 9.4% |
Payment(F) | 127 | $4.1M | 3.6% |
Purchase(P) | 92 | $3.3M | 3.0% |
Disposition(D) | 15 | $1.8M | 1.6% |
Award(A) | 137 | $784.8K | 0.7% |
Gift(G) | 6 | $0 | 0.0% |
Insider selling pressure at AxoGen, Inc. has increased, with 42 insiders executing 731 transactions across all time. Total sales of $91.9M significantly outpace purchases of $3.3M, resulting in a net outflow of $88.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.